3 American ETFs That Saw Fireworks to Start 2014 - ETF News And Commentary
Eric Dutram - ZACKS - Thu Jul 03, 11:00AM CDT
Several US focused ETFs put up gains of at least 20 percent to start 2014.
The Zacks Analyst Blog Highlights:Vertex Pharmaceuticals, Market Vectors Biotech ETF, iShares Nasdaq Biotechnology ETF, First Trust NYSE Arca Biotechnology Index Fund, PowerShares Dynamic Biotechnology & Genome Portfolio and SPDR S&P Biotech ETF
PR Newswire - Thu Jun 26, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Vertex Pharmaceuticals (Nasdaq:VRTX-Free Report), Market Vectors Biotech ETF (AMEX:BBH-Free Report), iShares Nasdaq Biotechnology ETF (Nasdaq:IBB-Free Report), First Trust NYSE Arca Biotechnology Index Fund (AMEX:FBT-Free Report), PowerShares Dynamic Biotechnology & Genome Portfolio (AMEX
Vertex Pharma Pushes Biotech ETFs Higher - ETF News And Commentary
Sweta Killa - ZACKS - Wed Jun 25, 1:00PM CDT
The positive trial results of a cystic fibrosis send Vertex Pharmaceuticals and these biotech ETFs higher on Tuesday trading session.
How Will Biotechnology ETFs Finish Out the Year? - ETF News And Commentary
Zacks Equity Research - ZACKS - Tue Jun 24, 9:00AM CDT
Which trend will prevail in the volatile biotechnology ETF space.
Two Biotech ETFs Surge on Idenix-Merck Deal - ETF News And Commentary
Sweta Killa - ZACKS - Tue Jun 10, 1:00PM CDT
Idenix Pharmaceuticals pushes these two biotech ETFs higher ahead of the rivals on Merck buyout.
A Comprehensive Guide to Biotech ETFs - ETF News And Commentary
Zacks Equity Research - ZACKS - Fri May 30, 7:00AM CDT
Despite recent volatility in the space, the longer-term fundamentals remain attractive.
Any Survivors from the Biotech ETF Meltdown? - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Mon Mar 31, 3:00PM CDT
Although all biotech ETFs crumbled last week, many might still be well positioned for the future.
First Trust Launches Dorsey Wright Focus 5 ETF - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 7:00AM CDT
Inside the new ETF from First Trust which takes a fund of funds approach.
New First Trust ETF Combines Two Successful Methodologies
at The Street - Fri Mar 07, 11:36AM CST
The new fund is a combination of quantitative screening and relative strength in a fund of funds.
12.0% Return Seen to Date on SmarTrend First Trust AMEX Biotechnology Index Fund Call (FBT)
Comtex SmarTrend(R) - Wed Feb 26, 10:05AM CST
SmarTrend identified an Uptrend for First Trust AMEX Biotechnology Index Fund (AMEX:FBT) on February 11th, 2014 at $77.20. In approximately 2 weeks, First Trust AMEX Biotechnology Index Fund has returned 11.98% as of today's recent price of $86.44.
The Guide to Surging Biotech ETFs - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Tue Feb 11, 11:00AM CST
Investors should not ignore this high growth sector that continues to deliver strong performance
Zacks Investment Ideas feature highlights: First Trust NYSE Arca Biotechnology Index Fund, Market Vectors Mortgage REIT Income ETF and PowerShares Preferred Portfolio
PR Newswire - Wed Feb 05, 8:30AM CST
Today, Zacks Investment Ideas feature highlights Features: First Trust NYSE Arca Biotechnology Index Fund (AMEX:FBT-Free Report), Market Vectors Mortgage REIT Income ETF (AMEX:MORT-Free Report) and PowerShares Preferred Portfolio (AMEX